Document is current
Any future updates will be listed below
-
Authors
Bishop, Timothy R. https://orcid.org/0000-0002-0321-7809
Subramanian, Chitra https://orcid.org/0000-0003-1101-5307
Bilotta, Eric M. https://orcid.org/0000-0001-7609-3037
Garnar-Wortzel, Leopold https://orcid.org/0000-0001-5055-7817
Ramos, Anissa R.
Zhang, Yuxiang
Asiaban, Joshua N.
Ott, Christopher J. https://orcid.org/0000-0001-6142-7241
Rock, Charles O. https://orcid.org/0000-0001-8648-4189
Erb, Michael A. https://orcid.org/0000-0001-9993-3481
- License Information
-
More Information
Article History
Received: 27 July 2022
Accepted: 23 March 2023
First Online: 1 May 2023
Competing interests
: T.R.B., E.M.B. and M.A.E. are listed as inventors of a patent application (US provisional application no. 63/336,806) related to cell-based screening assays and genetic determinants of HAT inhibitor resistance based on the findings of this manuscript. C.S. and C.O.R. are coinventors of US patent no. US10899734B2 (‘Small-molecule modulators of pantothenate kinase’) and pending US patent applications nos. 16/957,996 (‘Methods of treating disorders associated with CASTOR’) and 16/958,022 (‘Small-molecule modulators of pantothenate kinases’).
